GHK-Cu Before and After: Results, Week by Week

GHK-Cu Before and After: The Honest Version

Search this phrase and you get two kinds of page. One shows a split photo of a cheek after twelve weeks of a blue serum and calls it GHK-Cu Explore PeRxGHK-CuThe Skin Rejuvenation PeptideView peptide , which is accurate. The other describes a subcutaneous injection and borrows the serum's numbers, which is not. The human results that exist are topical: creams applied for 12 weeks to the faces of a few dozen women, reported mostly at a 2002 dermatology meeting and summarized ever since by the peptide's discoverer. As of October 2026, no published trial has given GHK-Cu by injection to people and measured what happened.

So the honest version is built from three piles that never touch: what the topical trials measured, what the injection data shows (animal work, nothing human), and what patients on a prescribed protocol say they notice. The mechanism lives in the GHK-Cu guide Read nextGHK-Cu Peptide: Benefits, Injections & EvidenceIn 1973, a biochemist at UCSF discovered that young blood makes old cells act young. The molecule responsible was the GHK peptide, a tiny copper-binding tripeptide that drops 60% by age 60 and influences thousands of your genes. Today, TikTok sells it as a $20 face cream. The injectable version does something fundamentally different: it reaches every tissue in your body and signals all of them to start repairing. Here's why that distinction matters more than any skincare trend.Read article and the unit arithmetic in the GHK-Cu dosage chart Read nextGHK-Cu Dosage Chart: Units, Schedule, Copper MathSearch for a GHK-Cu dosage chart and you get a Reddit thread and a handful of research-vendor pages, all quoting 1 to 2 mg per injection as if a trial had set it. No trial did. The human GHK-Cu data is almost entirely topical, and the injection figures are clinic convention. This page lays out those conventions as the ranges they are, then the one dose a licensed provider actually prescribes through PeRx: 20 units, 2 mg, Monday through Friday, from a 10 mg/mL vial. Units, weekly totals, the copper arithmetic, timing and missed doses, as of October 1, 2026.Read article ; this page covers what can change, in what order, and how you would know on your own face.

Three Kinds of Evidence, Kept Apart

Tier one: controlled topical trials. These are the only human GHK-Cu outcome data. Pickart and Margolina's 2018 review collects them: a facial cream used for 12 weeks by 71 women with photoaging, an eye cream used for 12 weeks by 41 women against placebo and a vitamin K cream, and a one-month thigh study that counted collagen in biopsies. The findings were higher skin density and thickness, less laxity and shallower fine lines. The cautions: small groups, conference abstracts rather than full papers, and reviews written by the peptide's discoverer, who also sells copper-peptide skincare.

Pickart L, Margolina A. "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data." International Journal of Molecular Sciences, 2018. (Review; section 2.2 summarizes the topical trials.) View study

Pickart L, Vasquez-Soltero JM, Margolina A. "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration." BioMed Research International, 2015. (Review; the "Facial Studies" section.) View study

Tier two: injection data. There is no human tier two. In 2026 a group with no commercial tie to the peptide published a systematic evidence map of everything tested with GHK-Cu through August of that year; their human record is four small topical studies, and they call GHK-Cu promising but unproven. A 2026 sports-medicine primer agrees: no clinical data, dosing and duration unknown. The injection pile contains animal work. In the best-known study, GHK-Cu injected into wound chambers under the skin of rats raised collagen and other matrix proteins dose-dependently. A rat, a wound and a chamber: that is the closest thing to an injection result that exists.

Mateescu DM, Gavrilescu DM, Mincioaga RI, et al. "GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap." Pharmaceutics, 2026. (Systematic evidence map; search cutoff 12 August 2026.) View study

Mayfield CK, Bolia IK, Feingold CL, et al. "Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians." American Journal of Sports Medicine, 2026. (Narrative review.) View study

Maquart FX, Bellon G, Chaqour B, et al. "In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds." Journal of Clinical Investigation, 1993. (Animal study.) View study

Tier three: patient reports. People on a prescribed protocol do notice things, and this page says what they report. Every such statement is anecdote: unblinded, unmeasured, and shaped by having paid for the vial. The cleanest demonstration of why that matters is a randomized topical study in 13 people after laser resurfacing: blinded evaluators and computer analysis found no difference between the groups at 12 weeks, yet the GHK-Cu users rated their own improvement significantly higher. Satisfaction moved; the measurements did not.

Miller TR, Wagner JD, Baack BR, Eisbach KJ. "Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin." Archives of Facial Plastic Surgery, 2006. (Randomized topical study, 13 completers.) View study

What the Topical Trials Measured at 4, 8 and 12 Weeks

At about four weeks the signal was histological: in the thigh study, women applied creams for one month and biopsies were examined for collagen, which rose in 70 percent of the GHK-Cu group against 50 percent for vitamin C and 40 percent for retinoic acid. That is the origin of every "beats vitamin C and retinol" line online, from a pilot study in a journal PubMed does not index, on a thigh biopsy, not a face.

At eight weeks, the 2018 review describes a small randomized serum trial reporting less wrinkle volume and depth against a control; that paper also sits outside PubMed, so treat its percentages as reported, not confirmed. At twelve weeks come the results that matter: the 71-woman facial trial and the 41-woman eye-cream trial measured higher skin density and thickness, less laxity, and shallower fine lines. Those are instrument readings, which is why these trials outrank any photo set. They are also cream readings: a cream acts where it is applied, an injection goes wherever circulation takes it, and nothing in these trials says whether a subcutaneous dose reaches the dermis of your face at a concentration that does what the cream did.

Hostynek JJ, Dreher F, Maibach HI. "Human skin penetration of a copper tripeptide in vitro as a function of skin layer." Inflammation Research, 2011. (In-vitro penetration study, not an efficacy result.) View study

What Changes First on the Injectable Protocol, and What Does Not

The PeRx prescription is specific: GHK-Cu at 10 mg/mL in a 5 mL vial, 20 units under the skin once daily, Monday through Friday. That is 0.2 mL, 2 mg per injection and 10 mg a week, with no cycling break; the standalone product is prescribed for continuous use. Three label rules shape your before-and-after: no copper supplements while using it, no vitamin C serums or supplements within two hours of the injection, and mild redness or bruising at the site is normal. Where to inject GHK-Cu Read nextWhere to Inject GHK-Cu: Sites and RotationGHK-Cu goes under the skin, once a day, five days a week. That schedule puts more demand on your rotation habit than a twice-weekly peptide does, and copper brings two handling rules nothing else in the catalog has. Here is how patients actually run it at home.Read article covers sites and rotation.

So the first "after" is unglamorous: a pink spot or small bruise where the needle went in, the one reliable effect of injected GHK-Cu, gone within days. Nothing about your face has changed by week one. What patients report next, typically between the third and sixth week, is smoother morning skin and blemishes that settle faster. By eight to twelve weeks the reports shift to firmness: a cheek that feels denser, fine lines that catch less light. Those reports run in the direction the cream trials measured, which is exactly why they must stay labeled as reports.

What does not change is the more useful list: weight, lost facial volume and significantly loose skin. A body transformation credited to GHK-Cu belongs to a GLP-1 medication or a training block, as the peptides before and after guide Read nextPeptides Before and After: What Actually ChangesSearch this phrase and you get a wall of Instagram screenshots and vendor transformation posts. Most of them are misleading, and the honest answer is more useful: what changes on a peptide protocol depends on the goal, and most of the real "after" is something a photo cannot capture. This guide walks through what typically changes for recovery, skin, weight, and energy goals, on what timeline, and how to run a before-and-after on yourself that you can actually trust.Read article explains, and the GHK-Cu after GLP-1 weight loss guide Read nextGHK-Cu for Skin After GLP-1 Weight LossThe honest version. Ozempic face is not something the drug did to your skin, it is what a face looks like when it loses fat quickly. That distinction decides which fixes are even in the right category. GHK-Cu has real evidence behind it for collagen and skin quality, and it has hard limits that nobody selling it likes to mention.Read article is blunt about the other two.

GHK-Cu

PeRx GHK-Cu is prescribed by a licensed provider after a health screening and compounded at a US-based 503A pharmacy at 10 mg/mL. It ships fully reconstituted and ready to use.

$229 per vial, sold as a one-month supply, for continuous Monday-through-Friday use.

Ready-to-use vial at 10 mg/mL; 20 units is 2 mg.

Shop Now

Skin: Texture, Firmness and the Appearance of Scars

Skin has the only human data, so it is where a before-and-after can be most honest. Texture and hydration come first in patient reports and appear in the topical trials as clarity and smoothing, which makes them the earliest plausible change and the hardest to photograph: hydration swings with sleep, salt, alcohol and the season far more than any peptide moves it. Firmness is the slower chapter. The cream trials read density and wrinkle depth at 12 weeks, and that is the earliest point at which a matched photo pair has a fair chance of showing anything; the peptides before your wedding guide Read nextPeptides Before Your Wedding: 90-Day Glow-UpThe countdown is on, and you want to look and feel like the best version of yourself. How peptide therapy is used in the months before a wedding for skin glow, body polish, calmer sleep, and the honeymoon.Read article does the calendar math.

Scars deserve their own honesty. The regenerative story is a wound story, well supported in animals. In people, the first controlled trial of a GHK-Cu product on fresh wounds, a topical gel, began recruiting in February 2026 with primary completion set for February 2027. Nobody has studied injected GHK-Cu on an old scar. Patients report that recent marks seem to settle faster; an old scar changing over months is an occasional report, nothing more.

"Topical GHK-Cu Gel for Acute Skin Wound Healing." ClinicalTrials.gov identifier NCT07437586. Phase 2, randomized, vehicle-controlled; recruiting as of October 2026, primary completion February 2027, no results posted. View study

Skincare forums describe a "copper uglies" phase, duller or rougher skin in the first weeks of a topical copper peptide before things improve. It is anecdote from serum users, never studied, and an injection whose peptide never sits on the skin surface gives no reason to expect it; skin that looks worse at week three usually has a new retinoid, a new sunscreen or a bad sleep week behind it. GHK-Cu vs retinol Read nextGHK-Cu vs Retinol for Skin: An Honest GuideRetinol and copper peptides get pitched as rivals on skincare TikTok, but they do not do the same job. Retinol speeds up how fast your skin sheds and rebuilds, which works well and comes with irritation. GHK-Cu is a signal peptide that tells skin to make collagen with far less drama. Here is the honest, mechanism-first comparison, including the part most beauty blogs miss: the difference between a copper peptide serum and a prescription injection.Read article covers why the two do different jobs; peptides for glowing skin Read nextPeptides for Glowing Skin (2026)Glow is a lay word, not a medical one. It usually means skin that looks even, firm, and hydrated rather than tired. This guide covers the injectable peptides in the PeRx catalog that have been studied for the biology behind that look: GHK-Cu, glutathione, NAD+, and Epitalon. What each one does, what the research actually supports, and where a topical serum fits instead.Read article puts GHK-Cu beside the other skin options.

Hair: What the Evidence Actually Covers

Hair is where GHK-Cu before-and-after content is least honest. The animal data is old and real: peptide-copper complexes stimulated follicles in C3H mice in 1991, and a copper-binding peptide enlarged follicles on fuzzy-rat skin in the same era. The human data is thinner than it looks. The follicle study most pages cite, a 2007 in-vitro paper, tested AHK-Cu, a different copper tripeptide. The one controlled scalp trial sprayed a GHK and 5-aminolevulinic acid complex on 45 men with pattern hair loss for six months; hair counts rose against placebo, thickness did not change, and a two-ingredient complex cannot isolate GHK. The newest entry is an 18-person 2026 split-face study of a 2 percent GHK-Cu serum on eyebrows, which the 2026 evidence map calls the strongest human signal while noting it was small and cosmetic.

Trachy RE, Fors TD, Pickart L, Uno H. "The hair follicle-stimulating properties of peptide copper complexes. Results in C3H mice." Annals of the New York Academy of Sciences, 1991. (Animal study.) View study

Uno H, Kurata S. "Chemical agents and peptides affect hair growth." Journal of Investigative Dermatology, 1993. (Animal data.) View study

Lee WJ, Sim HB, Jang YH, et al. "Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth." Annals of Dermatology, 2016. (Randomized, placebo-controlled; 45 men; topical two-ingredient spray.) View study

For injected GHK-Cu and hair there is no data of any kind. Some patients report fuller-feeling hair after a few months; some report nothing. Treat any change as a bonus.

The Week-by-Week Picture, Sourced

The usual schedule, rebuilt with one rule: every stage names the pile it came from, and topical measurements and patient reports never share a sentence. It assumes the prescribed protocol and a baseline photo set taken before dose one.

How to Run Your Own Before and After

Skin is the one peptide outcome a camera can testify to, which makes it the easiest to fake by accident. Window light changes by the hour, a phone applies smoothing you cannot fully turn off, and a different distance changes how a pore reads. The post-laser study showed that impressions run ahead of measurements, so this design takes your impression out of the loop.

Photos: same room, same lamp, same spot on the floor. Use an interior room with no window light and one fixed lamp, and mark where you stand and where the phone sits at face height. Same time of day, after washing, no makeup, hair back, neutral face, beauty and HDR settings off. Three frames, straight on and both profiles, then a fourth, close, of one area you care about: a cheek, the outer eye, one scar. Repeat on the same calendar day each month, not weekly; skin is noisy day to day and the only human data reads at 12 weeks.

A written baseline, before dose one. Rate texture and firmness from 1 to 10, note how many days a typical blemish takes to flatten, and list every product on your face; once you feel better you will forget how you felt before. One instrument, if you can get it. Clinics measure elasticity with a cutometer and skin thickness with ultrasound. A baseline and a 12-week reading from the same device is the closest a patient gets to a trial endpoint.

Then wait the full twelve weeks; the how long peptides take to work guide Read nextHow Long Do Peptides Take to Work?Anywhere from the same evening to several months, depending on which peptide and which change you are watching for. PT-141 is dosed for a same-day window while GHK-Cu skin remodeling is a months-long project, and most peptides land somewhere between. This guide maps the typically reported onset windows by peptide family, explains what tends to change first for each goal, and covers why feeling nothing early is often normal rather than a sign of failure.Read article explains why each peptide class runs on its own clock. Compare the sets side by side on a screen, and ask someone who does not know which is which to pick the better one.

When You See Nothing

Suppose you did it properly, twelve weeks passed, and the matched photos look the same. The photos first: if the lamp, distance or phone changed, the comparison is void, not negative. The window: eight weeks and a verdict is not a fair trial of a peptide whose only human data reads at twelve. The protocol: missed weekday doses, vitamin C right after the injection, or a copper supplement alongside all take you off the prescription that was written. Then the honest possibility: injected GHK-Cu may not do much for your skin. Nobody has measured what it does for anyone's, so a null result on one face is not a verdict on the molecule.

What to do with that is not to draw more units; the dose is fixed, and a bigger draw only raises the copper figure in the dosage chart Read nextGHK-Cu Dosage Chart: Units, Schedule, Copper MathSearch for a GHK-Cu dosage chart and you get a Reddit thread and a handful of research-vendor pages, all quoting 1 to 2 mg per injection as if a trial had set it. No trial did. The human GHK-Cu data is almost entirely topical, and the injection figures are clinic convention. This page lays out those conventions as the ranges they are, then the one dose a licensed provider actually prescribes through PeRx: 20 units, 2 mg, Monday through Friday, from a 10 mg/mL vial. Units, weekly totals, the copper arithmetic, timing and missed doses, as of October 1, 2026.Read article . Bring the photo set and the baseline notes to your provider. Sometimes a different peptide fits better, which Epitalon vs GHK-Cu Read nextEpitalon vs GHK-Cu: Longevity vs Tissue RepairThey get compared constantly, but they are not competing for the same job. Epitalon is a tetrapeptide studied for the cellular clock: telomeres, telomerase, and melatonin. GHK-Cu is a copper tripeptide that rebuilds visible tissue: skin, hair, and connective tissue. One works on how long your cells can keep dividing. The other works on what those cells actually build. Here is how they differ, when someone considers each, and why the two are often used together rather than either-or.Read article and BPC-157 vs GHK-Cu Read nextBPC-157 vs GHK-Cu: Acute Repair vs Tissue RemodelingBPC-157 sends growth factor signals to fix an injury now. GHK-Cu rewrites gene expression to reverse tissue aging over time. One is a first responder. The other is a renovation contractor. They solve fundamentally different problems, which is why some patients use both.Read article lay out, or the GHK-Cu and Epitalon vial Read nextGHK-Cu + Epitalon: Repair & Longevity Combo GuideOne peptide rebuilds tissue quality at the surface. The other protects the cellular machinery that makes rebuilding possible. GHK-Cu and Epitalon were discovered on different continents, decades apart, by researchers asking completely different questions about aging. The science points to an obvious fit: they cover non-overlapping levels of the same biological problem.Read article was the product in question; sometimes the goal was never a GHK-Cu goal, and a good topical routine and sunscreen were the proportionate tool.

Red Flags in GHK-Cu Before-and-After Content

Serum photos under an injection headline. The most common move on this search: a split image of a cheek after twelve weeks of copper-peptide cream, placed under a page about subcutaneous GHK-Cu, transfers a cream's evidence to a route that has none. Trial percentages with the route removed. "Collagen up in 70 percent" and "beats vitamin C and retinol" are topical findings from a few dozen women, accurate only with the word topical attached.

"4,000 genes" as a human result. The figure comes from the Connectivity Map, a computer comparison of how cultured cells respond to compounds. The emphysema paper that put GHK on that map is serious science, but it measured nothing in a living person, and no human study has profiled gene expression after a GHK-Cu injection.

Campbell JD, McDonough JE, Zeskind JE, et al. "A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK." Genome Medicine, 2012. (Connectivity Map analysis plus cultured fibroblasts; no human treatment.) View study

Pickart L, Vasquez-Soltero JM, Margolina A. "GHK and DNA: resetting the human genome to health." BioMed Research International, 2014. (Review of Connectivity Map and cell data.) View study

A hair study for a different peptide. The 2007 in-vitro follicle study is AHK-Cu. A procedure in the same window. Photos taken across a laser, filler or retinoid start are showing you the procedure. Promises with dates. No GHK-Cu study has produced "visible results in two weeks." No prescriber in sight. Injectable GHK-Cu is prescription-only and, as of October 2026, not FDA-approved for any use; is GHK-Cu FDA approved Read nextIs GHK-Cu FDA Approved? Regulatory Status (2026)No. GHK-Cu has never entered clinical trials for injection. But it has been used in topical skincare for over 40 years, and the Broad Institute's Connectivity Map revealed it modulates over 4,000 human genes. GHK-Cu is one of the most extensively researched peptides at the molecular level, with zero clinical trial investment. Here is why.Read article tracks the federal advisory review of its compounding status. Results imagery with no licensed provider or pharmacy behind it is selling an unregulated product.

GHK-Cu Before and After: Common Questions